Skip to the page

Data / Drug companies / Apister Lifesciences Private Limited

Apister Lifesciences Private Limited: 32 products in the FDA NDC directory, labeler code 87621

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Apister Lifesciences Private Limited (labeler code 87621) lists 32 products in the FDA National Drug Code Directory. By type: 32 bulk ingredients. Its main marketing category is bulk ingredients for compounding. The newest product started marketing on September 1, 2026.

The request: Watch Apister Lifesciences Private Limited (FDA labeler code 87621): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
87621
Products in commercial distribution
32
Packages
196
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Started marketing in the last 12 months
32
Earliest marketing start
August 4, 2026
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients for compounding32100%

Products by type

TypeProductsShare
Bulk ingredients32100%

Dosage forms

Dosage formProductsShare
Powder32100%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Choline chloride87621-038PowderBulk ingredients for compoundingSeptember 1, 2026
Tesamorelin acetate87621-035PowderBulk ingredients for compoundingAugust 21, 2026
Slu-pp-33287621-034PowderBulk ingredients for compoundingAugust 21, 2026
5-amino-1-methyl-1-quinolinium iodide anhydrous87621-033PowderBulk ingredients for compoundingAugust 21, 2026
Cjc-1295 acetate87621-032PowderBulk ingredients for compoundingAugust 21, 2026
Thymosin alpha-1 acetate87621-031PowderBulk ingredients for compoundingAugust 21, 2026
Anamorelin hydrochloride87621-029PowderBulk ingredients for compoundingAugust 21, 2026
Elamipretide (ss-31) acetate87621-030PowderBulk ingredients for compoundingAugust 18, 2026
Ibutamoren mesylate (mk 677)87621-037PowderBulk ingredients for compoundingAugust 13, 2026
Alprostadil87621-036PowderBulk ingredients for compoundingAugust 13, 2026
Ibutamoren mesylate (mk 677)87621-028PowderBulk ingredients for compoundingAugust 13, 2026
Alprostadil87621-027PowderBulk ingredients for compoundingAugust 13, 2026
Enclomiphene citrate87621-026PowderBulk ingredients for compoundingAugust 13, 2026
Metronidazole benzoate87621-025PowderBulk ingredients for compoundingAugust 12, 2026
Amlexanox ih87621-024PowderBulk ingredients for compoundingAugust 12, 2026
Vardenafil hydrochloride trihydrate87621-023PowderBulk ingredients for compoundingAugust 12, 2026
Tolazoline hydrochloride87621-022PowderBulk ingredients for compoundingAugust 12, 2026
Ivermectin87621-021PowderBulk ingredients for compoundingAugust 12, 2026
Dihexa acetate87621-020PowderBulk ingredients for compoundingAugust 7, 2026
Thymosin beta-4 fragment (tb 500) acetate87621-019PowderBulk ingredients for compoundingAugust 7, 2026
Nicotinamide adenine dinucleotide87621-018PowderBulk ingredients for compoundingAugust 7, 2026
Kpv acetate87621-007PowderBulk ingredients for compoundingAugust 7, 2026
Sermorelin acetate87621-017PowderBulk ingredients for compoundingAugust 6, 2026
Cidofovir dihydrate87621-016PowderBulk ingredients for compoundingAugust 6, 2026
Cidofovir anhydrous87621-015PowderBulk ingredients for compoundingAugust 5, 2026

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.